Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

NCT00016718 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Didanosine (ddI)
DRUG: Efavirenz (EFV)
DRUG: Emtricitabine (FTC)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]